Dr. Peter FitzGerald honoured with Cathaoirleach’s Reception in County Donegal
Our Founder and Managing Director, Dr. Peter FitzGerald, was this week honoured at a special Cathaoirleach’s Reception in Dungloe, Co. Donegal.
The reception, which was held in the Dungloe Public Service Centre on Tuesday 7th June, was hosted by the Cathaoirleach of Donegal County Council, Cllr Ciaran Brogan, to say thank you to Dr. FitzGerald for Randox’s job creation and investment in Randox Teoranta, Randox’s Donegal site.
Dr. FitzGerald established Randox Teoranta in Dungloe in 2008, as part of Randox’s global expansion plans. The facility currently employs around 100 people, with plans to increase this to 540 by 2020. Randox Teoranta is a highly innovative life-sciences, engineering, research and development and manufacturing centre playing a key role in realising Randox’s mission of improving clinical decision making worldwide.
Cllr Brogan said it was a great privilege for him to be in a position to honour Dr. FitzGerald with a special reception.
“Dr. FitzGerald’s accomplishments are immense, his contribution to the medical diagnostics sector, his commitment to continued research and development and his business acumen are testament to the work of a remarkable individual,” he said. “We are most grateful for his commitment to Dungloe and to County Donegal and to establishing a world class facility in our county, creating professional and highly skilled jobs in what is an exciting industry.
“Credit must also go to Údarás na Gaeltachta who have been strong supporters of this enterprise since it was established in Dungloe in 2008. Their ongoing commitment has seen Randox realise their vision of a world class research and manufacturing centre in Dungloe.
“By creating highly-skilled jobs, Randox now presents great opportunities for Donegal graduates living in other parts of the county and abroad to return to work in their own county.”
Dr. Peter FitzGerald, Founder and Managing Director of Randox, commented;
“I am incredibly grateful to Cllr. Ciaran Brogan, and to the team at Donegal County Council, for today’s event that recognises our commitment to County Donegal. Randox Teoranta in Dungloe is an integral part of our plans for Randox, a company committed to improving and saving lives through innovative diagnostics. Our scientists here are working on pioneering and life-saving research – world-class science that provides significant job opportunities for life scientists, engineers, software developers, and those in a range of associated manufacturing disciplines. We are excited by the potential of our Dungloe site in North West Donegal to transform the high value knowledge economy of the region.”
Also speaking at the event was Mr Seamus Neely, CEO, Donegal County Council CEO, Dr. Ciaran Richardson, Head of Randox Teoranta R&D, and Cllr. Marie Therese Gallagher, Donegal County Council.
The Wild Atlantic Adventure Race (WAAR), sponsored by Randox Teoranta, took place on Saturday 15th May this year, in the Rosses, West Donegal.
The WAAR route took over 400 participants on a 7.5k run across road and grasslands, including a run alongside two dramatic beaches at Carrickfin and Mullaghderg. The athletes had the chance to breathe in some of the Wild Atlantic air as they finished the run and got ready to cycle.
The next stage of the race was a 42.5k cycle along the Atlantic Coastline before climbing gently into the famous Hills of Donegal outside of Dungloe, where our Randox Teoranta site is located.
Finally the participants ended the race with a 1k Kayak challenge on the well-known waters of Mullaghdearg lake before running a couple of hundred metres down the large GAA pitch to the finish line.
Ciaran Richardson, Head of R&D at Randox Teoranta in Dungloe, commented;
“We are delighted to have partnered with the WAAR event, in our ongoing work to promote positive physical and mental health in the wider Donegal community. The race was an outstanding success, and we even had our own Randox Teoranta employees taking part – Michele Green, Eoghan O’Colla, Hugh Martin, Robert Farrell, Chris McNally, who recently won 1st place in the Randox Student Placement Awards Science Category, and Noel Diver, who came a very impressive 4th overall in WAAR, out of more than 400 participants! The feedback from our Randox team was fantastic – they highlighted the tight organisation of the event, the support offered throughout the challenge, and the beautiful Donegal scenery which they were able to take in along the way. On behalf of everyone here at Randox Teoranta, I would like to say a massive congratulations to all WAAR participants – what a fantastic achievement!”
The first WAARior to cross the finish line in this year’s WAAR event, was Sean McFadden with a very impressive time of 2:17:54, quickly followed by Martin Lynch and Neil McBride.
A full list of results can be found here.
Randox recently celebrated the contributions of its placement students at the annual Randox Pinnacle Placement Awards.
At Randox we work closely with a number of universities throughout the UK to support the professional and personal development of students, by providing work placements in our world-leading Engineering, Science and Business departments.
Students, past and present, have come from far and wide to work at Randox – from universities such as Queen’s University, Ulster University, St Andrew’s, Strathclyde, Imperial College London and University of Brighton.
This year, at the 2016 Randox Pinnacle Placement Awards, the top three students within each discipline have been rewarded for their outstanding contributions and this week were presented with certificates of merit and prizes to mark their achievements.
Receiving special recognition for his work was 21 year old Dean McGonagle from Limavady. The Aerospace Engineering student from Queen’s University, was awarded the Best Overall Placement Student, for his valued contributions to Randox.
Dean redesigned the Biochip storage module on Randox Evolution machines, and the changes he made are now being implemented into production analyser machines across the company.
Receiving his award Dean McGonagle said:
“I have really enjoyed seeing my designs actually being used within the Evolution analysers and how that is having a positive impact on the business. A particular highlight of my placement year was getting to travel to England to observe the shipping crate I had designed for the Evolution undergo environmental and distribution testing. I have really enjoyed my time at Randox, I’ve been involved in many different projects and have received lots of help and guidance from the great engineering team here.”
Congratulating Dean and his fellow placement students, Linda Magee, Head of Human Resources at Randox said:
“At Randox we are great advocates of a placement during a student’s time in education. In a company such as Randox, with operations on a global scale, the student is provided with some very valuable work experience in their discipline. It’s not just the student who benefits – we have the pleasure of working with a dynamic generation of students who bring with them extremely fresh and forward-thinking ideas.”
The top students in the Randox Pinnacle Placement Awards were:
- Dean McGonagle, Queen’s University Aerospace Engineering – Mechanical Design Team at Randox
- Jordan Thomson, Ulster University Computer Science – Software Team at Randox
- Marc McKee, Queen’s University Mechanical Engineering – Mechanical Design Team at Randox
- Christopher McNally, Ulster University Biomedical Science – Immunoassay Development Team at Randox
- William Heasley, Ulster University Biomedical Science – Biochip Customer Unit Team with Philip Holmes
- Kathryn Watt, St Andrew’s University Medicinal Chemistry – Synthetic Chemistry Team at Randox
- Meghan Semple, Ulster University Marketing – RX Marketing Team at Randox
- Fearghal Savage, Ulster University Information Technologies – IT Enterprise Support Team
- Michael Boyle, Ulster University Interactive Multimedia Design – Graphic Design Team at Randox
The incoming 2016-17 academic year marks the highest intake of placement students for Randox, with over 70 students starting in the company over the next few months. Anyone interested in applying for the 2017-18 scheme should email email@example.com.
Randox accompanied a group of musicians from across Northern Ireland and Ireland to Washington DC this weekend, for a world-class musical performance.
World-renowned chamber orchestra Camerata Ireland, the Harmony North choir, a cross-community choir made up of 9 post-primary school choirs from across North Belfast and the Codetta choir from Derry / Londonderry travelled to the US to perform on Saturday 21 May. The event took place in the Eisenhower Theater in America’s National Cultural Centre, The John F. Kennedy Centre for the Performing Arts, Washington DC.
The Codetta and Harmony North Choirs, and the Camerata Ireland orchestra, supported by global sponsor Randox, included in their performance a specially commissioned piece of music called ‘Dusty Bluebells’ – written by the poet Michael Longley, and Camerata founder and director Barry Douglas – on Saturday evening as part of the Centre’s International Festival, focusing on Irish arts and culture. The event also marked the world premiere of Olagon, a piece of music written by Belfast composter Neil Martin, and played by Dublin piper Mark Redmond, on the uilleann pipes.
Speaking ahead of the event, Barry Douglas, Founder and Artistic Director of Camerata Ireland, whose joint patrons are Her Majesty The Queen and the President of Ireland, said
“It is a real honour for Camerata Ireland to be asked to take part in this Festival with musical talent from both North and South. And I am doubly thrilled that we were able to accommodate my suggestion of being joined by the young people of the Harmony North choir.
Performances like this are only possible with the generous support of private sponsors, particularly our global sponsor Randox, and we are delighted to continue our partnership with them. I also have to thank the Arts Council of Northern Ireland, the Northern Ireland Bureau and Tourism Ireland for their generous financial assistance and help enabling us to attend this event.”
Barry and Eimear McGeown, a flautist from Craigavon, also performed at events in the Boston Public Library and the American Irish Historical Society in New York, attended by Randox guests on this recent trip to the US.
Randox Managing Director Dr. Peter FitzGerald, commented:
“We are very pleased to have been able to accompany Barry Douglas and Camerata Ireland at events in Washington, New York and Boston this week. To see our young musicians, including the young members of the exceptionally gifted Harmony North choir, showcase our musical heritage and talent to American audiences, makes us extremely proud. Our partnership with Camerata allows Randox the opportunity to promote client relationships and exports to the USA whilst simultaneously supporting the very best of our young musicians in their careers.”
Harmony North has been supported in their first year by the Integrated Education fund, Mr Tony Carson, the Belfast Trust for Integrated Education and the support of the schools, staff and parents of all the participating schools.
The Stroke Association works to improve stroke prevention, treatment and care with a vision for a world where there are fewer strokes. They host Stroke Awareness Month every year and “Make May Purple” to raise awareness of the ways to lower the risks of taking a stroke and to help those affected by it.
What is a stroke?
For the brain to function properly, it needs the oxygen and nutrients provided by the blood. Stroke occurs when a blood vessel in the brain bursts or, more commonly, when a blockage develops which leaves the supply of the blood to the brain limited or completely obstructed and without treatment; cells in the brain quickly begin to die.
If an individual is at risk or has suffered from a stroke before, medication is often recommended by doctors to lower the risk. Anti-platelet drugs, including Aspirin, keep platelets in the blood from sticking together and forming clots possibly preventing another stroke.
However, there are risks to taking Aspirin every day…
There can be risks of taking Aspirin and some experts do not recommend it if the individual hasn’t already had a stroke. The benefits of taking daily Aspirin therapy don’t outweigh the risk of bleeding in people with a low risk of strokes; although the higher the risk of stroke, the more likely it is that the benefits of daily Aspirin outweigh the risk of bleeding.
Taking daily Aspirin may help to reduce clot-related stroke but it also may increase the risk of a bleeding stroke known as haemorrhagic stroke. Daily Aspirin may also increase the risk of gastrointestinal bleeding, if an individual has a bleeding ulcer or if they are bleeding anywhere else in the gastrointestinal tract, taking Aspirin will cause it to bleed more. Also some individuals can be allergic to Aspirin and if they take any it can trigger a serious allergic reaction.
Not everyone responds in the same way to Aspirin!
For a number of reasons including genetic factors; other medications; dosage problems; diabetes; and elevated cholesterol, not all patients respond in the same way to Aspirin therapy. Aspirin resistance is a serious clinical problem and is estimated to affect up to 30% of patients on a low dosage. It is vital that Aspirin resistance is recognised as these patients may need their treatment altered to prevent dangerous clotting.
The TxBCardio™ test helps to identify patients who have a sub-optimum response to their Aspirin therapy. Patients who have a sub-optimum response to their Aspirin therapy are three times more likely to die from a stroke than those who respond positively to such therapy.
This Stroke Awareness Month, we are encouraging the testing of at-risk individuals to ensure that they are responding in the correct way to Aspirin therapy, by taking the TxBCardio™ test! This will not only help the tailoring of treatment to reduce the risk of stroke, but it will also ensure that patients are not exposed to any unnecessary risk of side-effects associated with daily Aspirin consumption.
For health professionals
The primary action of Aspirin is to inhibit the production of thromboxane in the blood, a chemical which helps to cause blood clotting. However, methods of directly measuring the level of thromboxane in blood are unreliable, and so not widely used. Randox TxBCardio™ measures a direct urinary metabolite of thromboxane, 11dhTxB, therefore providing a reliable and stable measure of a patient’s response to their daily Aspirin therapy. This test is available on most automated biochemistry analysers.
Contact us now to request a brochure or kit insert.
World Kidney Day is a global campaign aimed at raising awareness of the importance of our kidneys to our overall health. It aims to reduce the frequency and impact of kidney disease and its associated health problems worldwide.
The main objectives of World Kidney Day are to educate all medical professionals about their key role in detecting and reducing the risk of Chronic Kidney Disease (CKD), particularly in high risk populations, and to stress the important role of local and national health authorities in controlling the CKD epidemic. On World Kidney Day all governments are encouraged to take action and invest in further kidney screening.
World Kidney Day highlights the need for more accurate kidney function testing for better diagnosis and monitoring of kidney function to assist in the development of appropriate treatment plans. As such, Randox have invested in the development of more sensitive and specific renal function tests such as cystatin C, which may be requested if kidney function is found to be borderline using the more routinely run creatinine test. Doctors may request cystatin C to check for early kidney disease and/or to monitor known impairment over time.
Cystatin C is a particularly useful marker of renal function in patients where creatinine measurements are not suitable e.g. individuals who are obese, malnourished, have liver cirrhosis or reduced muscle mass. Importantly, unlike creatinine, cystatin C does not have a ‘blind area’ – up to 50% of renal function can be lost before significant creatinine elevation occurs. Cystatin C is extremely sensitive to very small changes in GFR and is therefore capable of detecting early stage kidney dysfunction.
Both World Kidney Day and Randox are working towards improving healthcare worldwide. With a comprehensive panel of high performance reagents, Randox are helping with the detection and characterisation of renal function problems. With early diagnosis it will be possible to keep kidney problems from getting worse, therefore lowering the number of those diagnosed with CKD worldwide.
If you are a clinician or lab interested in running renal function assays, Randox offers a large range of high quality routine and niche assays including: Cystatin C, Creatinine Enzymatic and Jaffe, Microalbumin, Urinary Protein, Urea, Sodium, Potassium, Albumin, Ammonia, β2- Microglobulin, Calcium, Chloride, Glucose, HbA1c, IgG, LDH, Magnesium, Phosphorus (Inorganic), and Uric Acid. These can be run on most automated biochemistry analysers.
Global innovative healthcare company, Randox Health, will become the new Official Partner of the world’s greatest race, the Grand National, and the three-day Grand National Festival staged at Aintree Racecourse.
Randox Health is a world leader in healthcare diagnostics; today more than 5% of the world’s population – in excess of 370 million people across 145 countries – receives medical diagnosis using Randox products each year.
Offering the world’s most advanced preventive health screening in their clinics, currently in London and Belfast, Randox Health plans to roll out clinics nationally and internationally over the next 12 months, including in Liverpool, Manchester, Edinburgh and Dublin. The Randox Health checks aim to prevent illness and enhance wellbeing by running hundreds of tests from one simple patient sample. These unique tests give an extraordinary insight into every aspect of a person’s health.
Founded in 1982 in County Antrim by leading medical scientist and keen horseman, Dr. Peter FitzGerald CBE, Randox Health is dedicated to improving health and enhancing lives, worldwide. To achieve their goals the company is committed to an extensive research programme, investing more than £220m since 1992. The company currently employs more than 1,400 people of 44 different nationalities.
This research has also led to the establishment of a number of successful subsidiary companies supporting forensic toxicology, food safety and veterinary care, as well as leading developments within the pharmaceutical industry.
With around 9 million people tuning in each year in the UK, the £1 million Grand National currently attracts one of the largest live TV audiences in sport and Channel 4’s largest audience of the year. From 2017, the first year with new partner Randox Health, the race will be broadcast on ITV. Worldwide the event attracts an estimated television audience of around 600 million, with more than 150,000 people enjoying the action live from Aintree Racecourse in Merseyside over the course of the three-day racing festival.
Randox Health also becomes the Official Healthcare Partner of The Jockey Club. Founded in 1750 and today British Racing’s largest commercial group, The Jockey Club runs many of the sport’s most iconic assets which as well as the Grand National Festival include the Cheltenham Festival, The Investec Derby Festival and The National Stud, with all profits going back into the sport thanks to being a company incorporated by Royal Charter.
Crabbie’s, Title Partner for the 2016 Grand National Festival being held 7th to 9th April and the previous two runnings, will retain its association with the Jump Racing spectacular, moving from 2017 to become sponsors of the Grade 1 Top Novices’ Hurdle on the Friday’s Ladies Day.
Dr. Peter FitzGerald CBE, Founder and Managing Director of Randox, said:
“The Randox Health team is extremely pleased to partner the world’s greatest race. The Grand National offers us a major public platform to raise awareness of preventative healthcare and to encourage people to take control of their health and wellbeing. We see this partnership as a natural fit, as both organisations invest heavily in the future and we aim to use our partnership to promote a positive lifestyle and to bring enjoyment to millions of people. We care about people’s health and this is the people’s race.
“Crabbie’s sponsorship of the Grand National will be a hard act to follow, but we look forward to rising to the challenge and sharing our vision for Randox Health further once the 2016 Crabbie’s Grand National has drawn to a close and our rights for the world’s greatest race come into effect.”
John Baker, North West Regional Director for Jockey Club Racecourses, who runs Aintree, said:
“I am delighted to welcome Randox Health as our new partner from after the 2016 Crabbie’s Grand National Festival. This is an incredibly exciting time to join forces with Randox because they are highly ambitious as a company and share our aspiration to promote the Grand National to the maximum number of people in the years ahead.
“We are already working closely with Randox Health and are excited both about their plans for the future and how they see the role of our partnership within that. Their vision, people and operation are very impressive, they love their racing and I am confident they will prove fantastic partners for our crown jewel.
“I should also like to thank Crabbie’s brand owner, Halewood International, and in particular Judy Halewood and Peter Eaton, for their very generous and beneficial support of the Crabbie’s Grand National these past three years. I am very pleased they will remain involved and associated with Aintree through sponsorship of the high value Grade 1 Top Novices’ Hurdle and of course before that the important 169th running of the world’s greatest steeplechase in April under their banner.”
For more information contact Randox PR on 028 9445 1016 or email firstname.lastname@example.org, or email@example.com
For further information on Randox Health, please visit www.randoxhealth.com
Immunoturbidimetry methods have become the main technique for performing protein tests. The transition from nephelometry has been cautious but is increasing as laboratories enjoy the comparability and flexibility of immunoturbidimetry.
Immunoturbidimetry and nephelometry both measure the turbidity of a sample to determine the level of an analyte. Upon addition of the assay reagent, antibodies and antigen cluster to form an immune complex that precipitates, increasing the turbidity of the sample. When light is passed through the reaction solution, some light is scattered by the sample, some light is absorbed by the sample and the rest passes through the sample.
Immunoturbidimetry measures the absorbance of the light by the sample, nephelometry measures the light scattered at a fixed angle. The level of analyte is determined by comparison with a calibrator of known concentration.
Immunoturbidimetry is ideal for the detection of proteins, where the analyte concentration is inversely proportional to the transmitted light signal. Historically nephelometry has been more sensitive than conventional immunoturbidimetry. In latex-enhanced immunoturbidimetry, inert microscopic particles enlarge the immune complexes, amplifying the reaction and significantly increasing the sensitivity of the reaction.
Nephelometers are dedicated analysers only capable of performing this type of assay. In addition, they are:
- have high consumable costs
- require highly trained personnel
Immunoturbidimetric tests are carried out on routine biochemistry analysers that are:
- offer longer reagent stability
The main advantage of nephelometry was its sensitivity; however latex-enhanced immunoturbidimetry has closed this gap. Immunoturbidimetric tests are an increasingly accepted alternative to nephelometry for specific protein assays, and studies have shown a close correlation between Randox immunoturbidimetric tests and nephelometry.
If you are interested in running your protein assays on a routine biochemistry analyser, Randox offers a large range of high quality routine and niche protein assays that can be run on most automated analysers, including: Alpha-I acid glycoprotein; alpha-I antitrypsin; anti-streptolysin O; apolipoprotein A-I; apolipoprotein A-II; apolipoprotein B; apolipoprotein C-II; apolipoprotein C-III; apolipoprotein E; ceruloplasmin; complement C3; complement C4; CRP; cystatin C; ferritin; haptoglobin; HbA1c; IgA; IgE; IgG; IgM; lipoprotein (a); microalbumin; myoglobin; rheumatoid factor; transferrin and transthyretin (prealbumin). For more information, download our Reagents Brochure or email: firstname.lastname@example.org.
On Friday 26th February, over 100 staff from 18 manufacturing departments of Randox gathered together at The Templeton Hotel in Templepatrick, to connect with colleagues, celebrate the success of Randox Manufacturing, and enjoy a delicious meal, at the annual Randox Manufacturing Awards Dinner.
David Martin, Senior Manager Manufacturing began the evening with his opening address, and thanked all attendees for their hard work;
“Each year our manufacturing department grows in strength and this is thanks to the people working in it. I am proud to be standing here to recognise our collective capabilities as a team and to celebrate our hard work – with good food and great company.”
Manufacturing Lean Co-Ordinator, Mark Campbell, then shared an overview of the year’s manufacturing successes, and looked forward to the activities for the year ahead.
On the night, Department of the year 2015 was awarded to the Auto Dispense team, and Zuzana Crossan from the Packing Department won Employee of the Year 2015.
David closed the night by congratulating Zuzana, and the Auto Dispense team;
“I’d like to take this opportunity to congratulate our award winners this evening – the Auto Dispense team and Zuzana Crossan – and to thank you all for the important part you play in making Randox a global leader in the diagnostics industry – manufacturing our products that we distribute all over the globe. Let’s look forward to an exciting and prosperous 2016 together, and I hope you enjoy the evening!”
This weekend marked one of the highlights of the Randox Events Calendar – the annual Farmer’s Breakfast, which took place on Saturday 20th February.
Local farmers, friends and neighbours arrived to share a delicious breakfast together in the Randox headquarters in Crumlin.
Dr. Peter FitzGerald, Managing Director of Randox Laboratories, commented;
“Our Farmers’ Breakfast is enjoyed every year by members of the local farming community, and this year was no exception. Old friendships were rekindled, and new ones made, as we all enjoyed a hearty breakfast from our headquarters in the beautiful Crumlin countryside. I would like to thank everyone who attended on Saturday, and hope that you enjoyed the morning as much as we did. Same time, same place next year!”